about
Direct transcatheter aortic valve implantation - one-year outcome of a case control study.The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.Coronary artery dissection, traumatic liver and spleen injury after cardiopulmonary resuscitation - a case report and review of the literature.Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.Transcatheter aortic valve replacement in bicuspid aortic valve disease.Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.Percutaneous Closure of Post-Infarction Ventricular Septal Defects-An Over Decade-long Experience.Improvement of quality of life following transcatheter aortic valve implantation in the elderly: a multi-centre study based on the Polish national TAVI registry.Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registry.Outcome prediction following transcatheter aortic valve implantation: Multiple risk scores comparison.Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe.Common carotid artery access for transcatheter aortic valve implantation.BleeMACS: rationale and design of the study.Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis.Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.Successful percutaneous coronary intervention after transcatheter aortic valve implantation with CoreValve bioprosthesis.Prosthetic valve endocarditis after transcatheter CoreValve Evolut R bioprosthesis implantationThe role of platelets in ST-segment elevation myocardial infarction.Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel.The long-term prognosis following acute coronary syndromes: a prospective observational study of unselected group treated in the 24/7 cardiac catheterization laboratory at university hospital.Complete percutaneous approach versus surgical access in transfemoral transcatheter aortic valve implantation - results from a multicenter registry.Risk factors for adverse outcomes of acute coronary syndrome patients - single center experience in long term follow-up of treated patients.Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention--radial versus femoral access (from the OCEAN RACE Trial).Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score.Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged withLeft ventricular remodelling pattern and its relation to clinical outcomes in patients with severe aortic stenosis treated with transcatheter aortic valve implantation.Augmented reality in left atrial appendage occlusion.Thromboelastography for predicting bleeding in patients with aortic stenosis treated with TAVI.Patient-prosthesis mismatch in patients treated with transcatheter aortic valve implantation - predictors, incidence and impact on clinical efficacy. A preliminary study.Holographic imaging during transcatheter aortic valve implantation procedure in bicuspid aortic valve stenosis.Access for percutaneous coronary intervention in ST segment elevation myocardial infarction: radial vs. femoral--a prospective, randomised clinical trial (OCEAN RACE).Cost-effectiveness of radial vs. femoral approach in primary percutaneous coronary intervention in STEMI - Randomized, control trial.PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentBaseline platelet reactivity in acute myocardial infarction treated with primary angioplasty--influence on myocardial reperfusion, left ventricular performance, and clinical events.Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI).Transcatheter implantation of an aortic valve prosthesis in a female patient with severe bicuspid aortic stenosis.Echocardiographic Assessment of Aortic Pulse-Wave Velocity: Validation against Invasive Pressure Measurements.Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention?Simultaneous acute closure of the right coronary artery and left anterior descending artery in a young male.
P50
Q34613431-F270D548-E57C-48C2-A734-6BB55C1A5AECQ37602424-F24847DC-CD92-48AF-A267-3C33A22853F7Q38183829-8FE4C3C7-311F-4E1B-9818-FB13915C9E02Q38386616-B4EB3C95-4086-4E30-8D4A-442FF64906CFQ38591597-3759AC2F-A18C-44BD-9404-00ADDFE1C086Q38607422-BFFE06AE-0307-4BD5-8E24-0AC9017A8933Q39025586-165F5150-FD5C-46CA-B925-7614A123D8ECQ39160147-86A6CC35-B36B-4384-9095-D7D69B22EF85Q39610008-FE90FA3E-C938-4355-A049-9C70B5403C08Q40164383-9A6269C4-C474-49C5-869D-DEA93807A248Q40661859-49DF228B-0138-42D9-B767-DF23D57BE9D9Q40720718-03657739-64F9-4B45-8C18-FE6CCE2DA932Q40941750-1485234D-654C-483C-820B-00C11F094D9BQ41017084-A5F979A0-6CBA-46CE-9E43-A9950A115135Q41968821-89BF9611-DEDD-4A21-9183-BA64035F0EECQ42118331-C60C454D-9859-46CF-9D35-FE088059DCBAQ42360028-AE168B56-44C3-4AFD-B56E-F07C4A67BA57Q43744485-07BABCC3-6420-430B-8FD5-A39AFF3E3D4FQ46520358-DC6F489A-542E-4CE4-B847-3C16511618E6Q47177912-66A9473D-B7DD-4E2A-A387-BDB99AF3DDE4Q47355446-4CC6647D-0D3E-46B3-B754-750A946F2CC5Q47723763-549CBBCB-2BC2-49EA-9622-C50D5C2623D3Q48070996-35CD4C12-E435-4CDC-9F4B-BFC4C2B5ADECQ48505168-3255462A-2146-493D-A901-ED54EA2A0161Q48840608-0CB21C6D-818B-4AA5-8AF2-0C0B63AC1ECCQ49329568-7037AE52-85C0-4FF5-BCE3-4A85766C45F7Q49331184-B7FE96EA-A473-4154-9663-0F2DE7CBE68EQ49383005-8DD3713D-2C46-429F-8097-E8A5984CAC5AQ49533724-1855366C-0FA2-4397-B1D9-CA265054917BQ50066576-53CC67DC-6948-4A3B-824A-8FC0C5724DC1Q50125079-F42DD80B-FF72-49C0-84CC-FC3C8F2426DDQ50185723-1AEE43EC-1BC3-4AA9-A5BF-36A1283BF75BQ50697336-65C740EF-5402-473E-A93B-39D8C5A918D7Q50936048-F5C27D83-FDD4-41B4-A04E-DFDD7C6227C7Q50973495-D7A7E8AC-7649-4AC3-AD55-313DFD1E6FDDQ51022291-9597F9D5-5274-4089-B8ED-5C607A0FDB5EQ51416882-3514CA86-C0B3-47E7-94DD-276F4AE26C0EQ51815847-450BAA01-C834-4DA5-BB87-8776E90C7E19Q51826087-8C6B0505-455B-49E7-A53B-C44CE6F77808Q53626768-1FA4E33B-49AA-4F35-B350-F2E9C26165B4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zenon Huczek
@ast
Zenon Huczek
@en
Zenon Huczek
@es
Zenon Huczek
@nl
Зенон Гучек
@uk
type
label
Zenon Huczek
@ast
Zenon Huczek
@en
Zenon Huczek
@es
Zenon Huczek
@nl
Зенон Гучек
@uk
prefLabel
Zenon Huczek
@ast
Zenon Huczek
@en
Zenon Huczek
@es
Zenon Huczek
@nl
Зенон Гучек
@uk
P106
P1153
6507834220
P21
P31
P496
0000-0002-5912-2649